Imbruvica 140MG 90S
Ended Awarded Last action
- Contract number
- SPE2DR26FAUBN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,382
Award facts
- Contract value 100% obligated
- $21,382.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order awards AmerisourceBergen Drug Corp $21,382.08 for the supply of Imbruvica 140mg tablets (90-count) through a firm fixed-price contract with the Defense Logistics Agency. The order was competitively awarded without set-aside designation and is scheduled for completion by February 10, 2026. Performance will occur at the company's corporate office location in Conshohocken, Pennsylvania. Imbruvica is a targeted cancer therapy used primarily in the treatment of certain lymphomas and leukemias, reflecting the critical pharmaceutical support that DLA Medical Supply Chain provides to military healthcare systems and veteran facilities.
This delivery order represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. As a prime pharmaceutical vendor under this comprehensive global IDC, AmerisourceBergen supplies an extensive range of medications, vaccines, medical devices, and healthcare commodities to support military treatment facilities and federal healthcare programs worldwide. The IDC structure provides the flexibility for DLA to issue multiple delivery orders for specialized pharmaceutical products as needed to meet operational requirements across the Department of Defense healthcare enterprise.
Quick answers
Who was awarded contract SPE2DR26FAUBN?
SPE2DR26FAUBN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FAUBN worth?
The government has obligated $21,382 on SPE2DR26FAUBN.
Is contract SPE2DR26FAUBN an order under another contract?
Yes. SPE2DR26FAUBN is a delivery order under SPE2DR25D6028, an indefinite delivery contract.
Was contract SPE2DR26FAUBN competed?
The extent of competition for SPE2DR26FAUBN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award